From July 20 to 22, the 16th China Pharmaceutical Strategy Conference and the Inaugural Conference of China Biomedical Industry and Education Integration Community, jointly sponsored by China Pharmaceutical University and China Pharmaceutical Industry Information Center, was held in Nanjing. Han Liming, Secretary of Municipal Party Committee, Sun Xianze, Chairman of China Pharmaceutical Society, Jin Nengming, Secretary of Party Committee of China Pharmaceutical University, Hao Haiping, President of China Pharmaceutical University, and academicians of the two academies of science, Zhang Lihe, Wang Guangji, Wang Junzhi, etc., attended the opening ceremony.
China Pharmaceutical Strategy Conference is characterized by creating a new integration ecology of "government, industry, academia, research and medical fund" in the health industry, which is the most significant wind vane in the industry. China Biomedical Industry-Education Integration Community is a scientific research organization established by China Pharmaceutical University under the guidance and support of relevant state ministries and commissions, in cooperation with national pharmacy schools, research institutes, research hospitals, national laboratories, and innovative enterprises, with the aim of promoting the fusion of industry and education, science and education, and deepening the fusion between institutions, industry and urban development, and striving for more original breakthroughs and the research and development of Chinese medicines that are suitable for the characteristics of Chinese life genes and physical qualities. The aim is to promote the integration of industry and education, deepen the integration of science and industry, and urban development, and strive to achieve more original breakthroughs, develop and produce more Chinese medicines suitable for the characteristics of Chinese genes and physical quality.
Han Liming said in his speech that in recent years, Nanjing has vigorously promoted the development of the biomedical industry from "running alongside" to "innovation breakthrough", from "multi-point layout" to "cluster development", from "geese formation" to "chain master driven", from "one-way support" to "chain master driven". The development of biopharmaceutical industry has been vigorously promoted from "following and running" to "innovation breakthrough", from "multi-point layout" to "cluster development", from "geese formation cultivation" to "chain-driven", from "one-way support" to "system ecology", and from "system ecology" to "system ecology". "System ecology", has become one of the most dynamic and advantageous cities in the development of biomedicine in China. The next step will be to study and implement the spirit of the Third Plenary Session of the 20th CPC Central Committee, fully integrate the resources of science, education, production and talent, actively build a through-transformation system of scientific and technological achievements, cultivate an open, inclusive and dynamic innovation environment, create a financial system to support the transformation of basic scientific research and applied technology, support and build a number of universities and scientific research institutes to carry out basic research, and support a number of enterprises or organizations to transform the results of basic scientific research, so as to build a biomedical city with long-lasting efforts. organizations, and build a highland for the development of the biomedical industry over time.
Sun Xianze said that the biopharmaceutical industry is a knowledge-intensive, capital-intensive high-tech industry, which requires the collaborative research of universities, enterprises, research institutes, societies and associations. It is expected that all parties rely on the construction of the community to promote the high level of creation and efficient transformation of university achievements, strengthen the basic research of new drug creation, and continuously strengthen the foundation of China's innovative drug development.
Jin Nengming said that China Pharmaceutical University is looking forward to working with all walks of life to build and form an all-round, three-dimensional, open and synergistic innovative drug ecosystem, and strive to become a source of new quality productivity in the field of biomedicine by cultivating top-notch innovative talents in pharmacy, enhancing the ability of new drug creation, and promoting the transformation of scientific and technological achievements.
Wei Shuyuan, Chairman of China General Research Institute of Pharmaceutical Industry, Deng Lihong, Deputy Director of Development Planning Department of Ministry of Education, and Wang Xiaoyang, Deputy Director of Consumer Goods Industry Department of Ministry of Industry and Information Technology, delivered speeches successively. Nanjing Institute of Biomedical Innovation and Transformation was inaugurated, and the high-end think tank of biomedicine was launched. China Pharmaceutical University and Shanghai Pharmaceuticals, Simcere Pharmaceuticals, Renfo Pharmaceuticals, Spray Bio-enterprise cooperation projects were signed, and Jiangning Hi-Tech Zone made industrial promotion.
Municipal leaders Lin Tao, Wu Wei, the provincial departments responsible for comrades and so on.
